These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 7981648

  • 1. Diagnostic and prognostic role of plasma and urinary sialic acid in human carcinoma of uterine cervix.
    Balasubramaniyan N, Subramanian S, Sekar N, Bhuvarahamurthy V, Govindasamy S.
    Biochem Mol Biol Int; 1994 Jul; 33(4):617-23. PubMed ID: 7981648
    [Abstract] [Full Text] [Related]

  • 2. Correlation of serum sialic acid fractions as markers for carcinoma of the uterine cervix.
    Lagana A, Martinez BP, Marino A, Fago G, Bizzarri M.
    Anticancer Res; 1995 Jul; 15(5B):2341-6. PubMed ID: 8572649
    [Abstract] [Full Text] [Related]

  • 3. Importance of serum sialic acid and lactate dehydrogenase in diagnosis and treatment monitoring of cervical cancer patients.
    Patel PS, Rawal GN, Balar DB.
    Gynecol Oncol; 1993 Sep; 50(3):294-9. PubMed ID: 8406190
    [Abstract] [Full Text] [Related]

  • 4. Prognostic index potential of urinary sialic acid in carcinoma uterine cervix.
    Shanmugam V, Nagarajan B.
    Indian J Med Res; 1988 Jan; 87():52-5. PubMed ID: 3360484
    [No Abstract] [Full Text] [Related]

  • 5. CA 125, NB/70K, and lipid-associated sialic acid in monitoring uterine papillary serous carcinoma.
    Tseng PC, Sprance HE, Carcangiu ML, Chambers JT, Schwartz PE.
    Obstet Gynecol; 1989 Sep; 74(3 Pt 1):384-7. PubMed ID: 2761916
    [Abstract] [Full Text] [Related]

  • 6. Total and lipid-bound plasma sialic acid as diagnostic markers in colorectal cancer patients: correlation with cathepsin B expression in progression to Dukes stage.
    Sebzda T, Saleh Y, Gburek J, Warwas M, Andrzejak R, Siewinski M, Rudnicki J.
    J Exp Ther Oncol; 2006 Sep; 5(3):223-9. PubMed ID: 16528972
    [Abstract] [Full Text] [Related]

  • 7. Serum sialic acid (TSA/LSA) and carcinoembryonic antigen (CEA) levels in cancer patients undergoing radiotherapy.
    Stringou E, Chondros K, Kouvaris J, Kakari S, Papavassiliou K.
    Anticancer Res; 1992 Sep; 12(1):251-5. PubMed ID: 1567173
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of serum sialic acid, heat stable alkaline phosphatase and fucose as markers of breast carcinoma.
    Patel PS, Baxi BR, Adhvaryu SG, Balar DB.
    Anticancer Res; 1990 Sep; 10(4):1071-4. PubMed ID: 2382978
    [Abstract] [Full Text] [Related]

  • 9. Importance of glycoproteins in human cancer.
    Patel PS, Raval GN, Rawal RM, Patel MM, Balar DB, Patel DD.
    Indian J Biochem Biophys; 1997 Sep; 34(1-2):226-33. PubMed ID: 9343956
    [Abstract] [Full Text] [Related]

  • 10. [Diagnostic value of total and lipid-bound sialic acid in malignancies].
    Cylwik B, Chrostek L, Szmitkowski M.
    Pol Merkur Lekarski; 2005 Aug; 19(110):237-41. PubMed ID: 16245443
    [Abstract] [Full Text] [Related]

  • 11. Serum sialic acid, fucose, sialic acid/fucose ratio as tumor markers in oral cancer.
    Ghosh M, Nayak BR.
    Ann Dent; 1991 Aug; 50(2):33-5, 48. PubMed ID: 1785913
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical significance of total and lipid bound sialic acid levels in oral pre-cancerous conditions and oral cancer.
    Rajpura KB, Patel PS, Chawda JG, Shah RM.
    J Oral Pathol Med; 2005 May; 34(5):263-7. PubMed ID: 15817068
    [Abstract] [Full Text] [Related]

  • 14. Studies on variations of glycoproteins and lysosomal hydrolases in human uterine cervical carcinoma.
    Bhuvarahamurthy V, Balasubramanian N, Subramanian S, Govindasamy S.
    Biochem Int; 1992 Oct; 28(1):105-11. PubMed ID: 1445383
    [Abstract] [Full Text] [Related]

  • 15. Sialic acid levels in various types of cancer.
    Kökoğlu E, Sönmez H, Uslu E, Uslu I.
    Cancer Biochem Biophys; 1992 Oct; 13(1):57-64. PubMed ID: 1343847
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Plasma sialic acid alterations in neoplastic diseases.
    Dwivedi C, Dixit M, Kumar SS, Reddy H, Semenya KA, Hardy RE.
    J Med; 1987 Oct; 18(5-6):323-32. PubMed ID: 3505259
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Usefulness of sialic acid as a tumor marker].
    Feliú J, Daimiel E, Vicente J, Martín G, García Girón C, Chacón I, González Barón M.
    Rev Clin Esp; 1989 May; 184(8):401-3. PubMed ID: 2781072
    [Abstract] [Full Text] [Related]

  • 20. Serum sialic acid forms as markers for head and neck malignancies.
    Bhatavdekar JM, Vora HH, Patel DD.
    Neoplasma; 1988 May; 35(4):425-34. PubMed ID: 3185839
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.